Each one of the 26 respondents who brought documentary features to Sundance in 2025 has their own fascinating set of ...

Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price ...

It's shaping up to be a big year for robot vacuums. Some of the most exciting new robot vacuum tech we saw at CES included in ...

Anything short of a state championship would fall well below the undefeated Kamiah Kubs' expectations. With a month left in the boys basketball regular season, the Kubs have certainly looked the part.

The Lobos’ home arena, aptly named The Pit, is considered one of the tougher arenas to visit in the Mountain West — last week ...

Leerink Partners maintained a positive outlook on shares of Eli Lilly and Company (NYSE:LLY) shares, reiterating an Outperform rating and a price target of $950.00. The pharmaceutical giant, currently ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

Salesforce has given $1 million to College Possible, the national nonprofit promoting college access by students from ...

announced today detailed results from the Phase 3 SURMOUNT-1 three-year study (176-week treatment period), the longest completed study to date of tirzepatide. Weekly tirzepatide (Zepbound® and ...

Image: Adobe Stock SURMOUNT-OSA consisted of two phase 3 trials in which adults with obesity and moderate or severe OSA were randomly assigned to once-weekly tirzepatide or placebo for 1 year.

The surrender of sovereignty over the whole of Cyprus is an existential obstacle that no Greek Cypriot leader could surmount In his traditional Christmas homily Archbishop Georgios of Cyprus ...